1
|
Courtinard C, Gourgou S, Jacot W, M. Carton, Filleron T, Couch D, Asselain B, Le Deley MC, Vacher L, Antoine A, Parent D, R. Schiappa, Breton M, Michiels S, Brain E, Guérin O, Loeb A, Perrocheau G, Simon G, Bellera C. 250P Association between progression free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: Evidence from the ESME real-world database. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
2
|
Prunty M, Rhodes S, OBrian D, Jesse E, Callegari M, Arenas-Gallo C, Halpern J, Calaway A, Loeb A, Shoag J, Thirumavalavan N. Penile Prosthesis Utilization After Radical Cystoprostatectomy for Bladder Cancer. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.01.366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
3
|
Jesse E, Sellke N, Muncey W, Ghayda RA, Loeb A, Thirumavalavan N. Cost Analysis of Online Telehealth Platforms Offering Testosterone Therapy. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.01.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Jesse E, Sellke N, Muncey W, Callegari M, Harris D, Kim T, Ghayda RA, Loeb A, Thirumavalavan N. Is Reddit a Reliable Source for Information on Erectile Dysfunction Treatment? J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.01.402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Belaroussi Y, Cousin S, Carton M, Lebitasy M, Laborde L, Laurent C, Filleron T, Fajole G, Dejean V, Parent D, Loeb A, Habet T, Chambon A, Desroys du Roure V, Faralli H, Lebouc M, Pallenchier S, Simon G, Martin A, Mathoulin-Pélissier S. Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment. Rev Epidemiol Sante Publique 2021. [DOI: 10.1016/j.respe.2021.04.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
6
|
Mishra K, Bukavina L, Long L, Sherif R, Ray A, Fernstrum A, Thirumavalavan N, Gupta S, Ghannoum M, Loeb A. 146 Do Antifungals and Local Anesthetic Affect the Efficacy of Antibiotic Dipping Solution? A Detailed Investigation of the Practice Across Multiple Species. J Sex Med 2021. [DOI: 10.1016/j.jsxm.2021.01.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Callegari M, Jella T, Mahran A, Muncey W, Gupta K, Omil-Lima D, Loeb A, Thirumavalavan N. 033 Trends in Testosterone Prescription Modalities Amongst Medical Specialties: A 5-year CMS Data Analysis (2013-2017). J Sex Med 2021. [DOI: 10.1016/j.jsxm.2021.01.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Muncey W, Mishra K, Avila A, Bukavina L, Mahran A, Raina R, Sidagam V, Sheyn D, Ponsky L, Thirumavalavan N, Gonzalez C, Ray A, Loeb A. 155 Intensity of Preoperative testing for Urethroplasty and its association with outcomes- A Propensity Score-Matched Analysis. J Sex Med 2020. [DOI: 10.1016/j.jsxm.2019.11.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
9
|
Loeb A, Shah B, Baumgarten A, Parker J, Carrion R. 043 The “Carrion Cast”: Intracorporal Antimicrobial Cast Using Synthetic High Purity CaSO4 for the Treatment of Infected Penile Implant – “Updated” Surgeon Protocol. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
10
|
Mishra K, Bukavina L, Mahran A, Bobrow A, Buzzy C, Jain N, Gnessin E, Ponsky L, Loeb A. 152 Variability in Cash Prices for Erectile Dysfunction Medications – Are All Pharmacies the Same? J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
11
|
Beilan J, Baumgarten A, Slongo J, Loeb A, Carrion R. 209 Post-IPP Glans Necrosis: Successful Management with Debridement and Tissue Membrane Allograft. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.01.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Olympios N, Lambertini M, Calbrix C, Saint-Ghislain M, Fontanilles M, Loeb A, Leheurteur M, Demeestere I, Di Fiore F, Perdrix A, Clatot F. Impact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy270.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
Shah B, Loeb A, Beilan J, Baumgarten A, Slongo J, Parker J, Carrion R. 334 Intraoperative management algorithm for urethral injury at the time of PP placement. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.297] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
14
|
Baumgarten A, Shah B, Binner M, Beilan J, Loeb A, Parker J, Carrion R, Slongo J. 070 Penile prosthesis placement in the setting of prolonged refractory ischemic priapism: a single institution experience. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.04.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Saghatchian M, Carton M, Piot I, Pérol D, Pistilli B, Brain E, Ghouadni A, Ricci F, Vanlemmens L, Loeb A, Levy C, Goncalves A, Dalenc F, Lefeuvre-Plesse C, Campone M, Jaffre A, Gourgou S, Cailliot C, Robain M, Dieras V. Abstract P5-20-03: Impact of prior adjuvant trastuzumab (aT) on clinical characteristics, patterns of recurrence and outcome in 2863 patients with Her2 positive (HER2+) metastatic breast cancer (MBC)- Results from the French ESME UNICANCER program. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p5-20-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The management of HER2+ BC has changed dramatically with the introduction and widespread use of HER2-targeted therapies, especially in the adjuvant setting. However, there is relatively limited real-world information on the impact of adjuvant Trastuzumab (aT) on patterns of recurrence and outcome of HER2+ MBC.
Methods: In 2014, the 18 French Cancer Centers launched the Epidemiological Strategy and Medical Economics (ESME) program to provide real-world data on MBC patients (pts). All pts who started a 1st-line treatment for MBC between 01-Jan-2008 and 31-Dec-2014 were included. We examined clinical characteristics and outcomes (overall survival [OS] and time to next treatment [TNT]) in patients with HER2+ MBC pretreated with trastuzumab in the adjuvant setting (aT) compared with trastuzumab-naïve patients (nT) and patients with de novo HER2+ MBC (dn). Multivariate analyses adjusted for baseline demographic, prognostic factors and year of diagnosis (prior or after 2005, when aT was approved and widely administered in France for early HER2+ breast cancer).
Results: Among the 15170 pts of the ESME database, 2863 (19%) were HER2+: 1093 pts (38%) had de novo and 1765 pts (62%) recurrent MBC; 63% were Hormone Receptor (HR) +; 54%, 25% and 21% had respectively 1, 2, or > 2 metastatic sites (68% visceral and 12% brain). Median time to 1st metastasis was 43.4 months (m) (95% CI: 24.6-84.4): 54 m in HR+ and 30 m in HR-. Among pts with recurrent MBC, 55% (995) had received aT. As 1st-line therapy for MBC, 90 % of pts received HER2-targeted agents (73% T-based). With a median follow-up of 46 m, median OS is 45 m (95% CI: 42.5-48). OS is significantly higher in de novo compared to recurrent MBC: 54 m (95% CI: 50.2-60.4) vs. 38.4 m (95% CI: 36.7-41.9), (p < 0.0001). Among pts with recurrent cancers, median OS is inferior in pts who had received aT, as compared to those who had not: 33.4 m (95% CI: 29.6-36.7) vs. 49.5 m (95% CI: 44.3-56.8), (p < 0.0001). Statistically significant differences persist after adjustment for age at MBC, disease-free interval, metastatic sites and RH status in the multivariate model (HR=1.45, 95% CI: 1.26-1.67) but not after adjustment for year of diagnosis (prior or after 2005) (HR=0.90, 95% CI: 0.70-1.15).
Conclusions: These large-scale real-world data in patients with HER2+ MBC provide evidence that the survival outcome remain similar in patients with failure of adjuvant trastuzumab compared with trastuzumab-naïve patients after adjustment for year of diagnosis. De novo HER2+ MBC pts have the best outcomes. Data on clinical characteristics of metastasis and time to next treatment for the three subgroups will be presented at the meeting.
Citation Format: Saghatchian M, Carton M, Piot I, Pérol D, Pistilli B, Brain E, Ghouadni A, Ricci F, Vanlemmens L, Loeb A, Levy C, Goncalves A, Dalenc F, Lefeuvre-Plesse C, Campone M, Jaffre A, Gourgou S, Cailliot C, Robain M, Dieras V. Impact of prior adjuvant trastuzumab (aT) on clinical characteristics, patterns of recurrence and outcome in 2863 patients with Her2 positive (HER2+) metastatic breast cancer (MBC)- Results from the French ESME UNICANCER program [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P5-20-03.
Collapse
Affiliation(s)
- M Saghatchian
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - M Carton
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - I Piot
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - D Pérol
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - B Pistilli
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - E Brain
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - A Ghouadni
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - F Ricci
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - L Vanlemmens
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - A Loeb
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - C Levy
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - A Goncalves
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - F Dalenc
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - C Lefeuvre-Plesse
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - M Campone
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - A Jaffre
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - S Gourgou
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - C Cailliot
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - M Robain
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| | - V Dieras
- Institut Gustave Roussy, Villejuif, France; Institut Curie; Unicancer; Centre Oscar Lambret; Centre François Baclesse; Institut Paoli-Calmettes; Institut Claudius Regaud; Centre Eugène Marquis; Institut de Cancérologie de l'Ouest - René Gauducheau; Institut Bergonié; ICM-Montpellier Cancer Institute
| |
Collapse
|
16
|
David M, Leprêtre S, Loeb A, Lamoureux F, Grenet J, Perdrix A, Bastard C. BU-24 - Évaluation rétrospective de la prophylaxie antifongique par posaconazole en hématologie. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30348-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Soumagnac MT, Barkana R, Sabiu CG, Loeb A, Ross AJ, Abdalla FB, Balan ST, Lahav O. Large-Scale Distribution of Total Mass versus Luminous Matter from Baryon Acoustic Oscillations: First Search in the Sloan Digital Sky Survey III Baryon Oscillation Spectroscopic Survey Data Release 10. Phys Rev Lett 2016; 116:201302. [PMID: 27258862 DOI: 10.1103/physrevlett.116.201302] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/04/2015] [Indexed: 06/05/2023]
Abstract
Baryon acoustic oscillations in the early Universe are predicted to leave an as yet undetected signature on the relative clustering of total mass versus luminous matter. A detection of this effect would provide an important confirmation of the standard cosmological paradigm and constrain alternatives to dark matter as well as nonstandard fluctuations such as compensated isocurvature perturbations (CIPs). We conduct the first observational search for this effect, by comparing the number-weighted and luminosity-weighted correlation functions, using the SDSS-III BOSS Data Release 10 CMASS sample. When including CIPs in our model, we formally obtain evidence at 3.2σ of the relative clustering signature and a limit that matches the existing upper limits on the amplitude of CIPs. However, various tests suggest that these results are not yet robust, perhaps due to systematic biases in the data. The method developed in this Letter used with more accurate future data such as that from DESI, is likely to confirm or disprove our preliminary evidence.
Collapse
Affiliation(s)
- M T Soumagnac
- Department of Particle Physics and Astrophysics, Weizmann Institute of Science, Rehovot 76100, Israel
| | - R Barkana
- Raymond and Beverly Sackler School of Physics and Astronomy, Tel Aviv University, Tel Aviv 69978, Israel
- Institut d'Astrophysique de Paris, Institut Lagrange de Paris, CNRS, UPMC Université Paris 06, UMR7095, 98 bis, Boulevard Arago, F-75014 Paris, France
- Department of Astrophysics, University of Oxford, Denys Wilkinson Building, Keble Road, Oxford OX1 3RH, United Kingdom
| | - C G Sabiu
- Korea Astronomy and Space Science Institute, 776, Daedeokdae-ro, Yuseong-gu, Daejeon 305-348, Korea
| | - A Loeb
- Astronomy Department, Harvard University, 60 Garden Street, Cambridge, Massachusetts 02138, USA
| | - A J Ross
- Center for Cosmology and Astro-Particle Physics, The Ohio State University, 191 West Woodruff Avenue, Columbus, Ohio 43210, USA
| | - F B Abdalla
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E6BT, United Kingdom
- Department of Physics and Electronics, Rhodes University, PO Box 94, Grahamstown 6140, South Africa
| | - S T Balan
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E6BT, United Kingdom
| | - O Lahav
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E6BT, United Kingdom
| |
Collapse
|
18
|
Guesmia T, Robain M, Perol D, Favier B, Berchery D, Cauchois D, Piot I, Payen O, Courtinard C, Doly A, Guizard A, Loeb A, Perrocheaux G, Mons M, Velten M, Simon G. Plateforme de données de vie réelle ESME. Constitution d’une liste de sélection exhaustive multi-source. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
19
|
|
20
|
Farghaly T, Israel S, Marconi M, Loeb A, Goldfarb J, Ahmady A. Ice blockers improve vitrification outcome of mouse embryos by allowing lower cryoprotectant concentration in vitrification media within a closed system. Fertil Steril 2012. [DOI: 10.1016/j.fertnstert.2012.07.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Chakraborti S, Ray A, Soderberg AM, Loeb A, Chandra P. Ultra-high-energy cosmic ray acceleration in engine-driven relativistic supernovae. Nat Commun 2011; 2:175. [DOI: 10.1038/ncomms1178] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2010] [Accepted: 01/05/2011] [Indexed: 11/09/2022] Open
|
22
|
Chourin S, Georgescu D, Gray C, Guillemet C, Loeb A, Veyret C, Basuyau JP. Value of CA 15-3 determination in the initial management of breast cancer patients. Ann Oncol 2009; 20:962-4. [PMID: 19299552 DOI: 10.1093/annonc/mdp061] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
23
|
Chourin S, Veyret C, Chevrier A, Loeb A, Gray C, Basuyau J. [Routine use of serial plasmatic CA 15-3 determinations during the follow-up of patients treated for breast cancer. Evaluation as factor of early diagnosis of recurrence]. Ann Biol Clin (Paris) 2008; 66:385-392. [PMID: 18725339 DOI: 10.1684/abc.2008.0244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2007] [Accepted: 03/03/2008] [Indexed: 05/26/2023]
Abstract
PURPOSE at our institution, CA 15-3 assays are routinely used for the early diagnosis of recurrence during the follow-up of patients treated for breast cancer, although published guidelines do not recommend this procedure. So, we decided to totally re-assess the usefulness of this policy. PATIENTS AND METHODS all records of patients presenting a first recurrence, local (50 cases) or metastatic (88 cases), of breast cancer during 2003 were re-examined. An increase in CA 15-3 concentration of more than 25% was considered significant. RESULTS an increase was observed in 18% of non metastatic recurrences. These increases had a prognostic value. CA 15-3 levels remained stable in 23% of metastasis cases and increased in 77%. In 14% of cases, the increase in CA 15-3 levels confirmed a clinically or radiologically suspected metastasis. Moreover, increased CA 15-3 levels in the absence of suggestive clinical or radiological signs led to the diagnosis in 18% of metastasis, 50% of which involved the bone. CONCLUSION our study demonstrates that CA 15-3 is useful for the early diagnosis of recurrence. Eighteen per cent of metastases were diagnosed by a marker increase alone. CA 15-3 assays could be useful in the early management of these metastases in patients treated for breast cancer.
Collapse
Affiliation(s)
- S Chourin
- Laboratoire de biologie clinique, Centre Henri-Becquerel, Rouen
| | | | | | | | | | | |
Collapse
|
24
|
|
25
|
Jacobson P, Loeb A. Ueber Verbindungen aus der
meta
‐Reihe des Diphenyls und die Constitution der aus parasubstituirten Hydrazoverbindungen entstehenden Diphenylbasen. ACTA ACUST UNITED AC 2006. [DOI: 10.1002/cber.19030360471] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
26
|
Affiliation(s)
| | - A. Loeb
- I. Berliner Universitäts‐Laboratorium
| |
Collapse
|
27
|
|
28
|
Shaw JA, Lewis JE, Loeb A, Rosado J, Rodriguez RA. A comparison of Hispanic and African-American sexually abused girls and their families. Child Abuse Negl 2001; 25:1363-1379. [PMID: 11720384 DOI: 10.1016/s0145-2134(01)00272-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
OBJECTIVE To study the differential effects of sexual abuse on Hispanic (HN) and African-American (AA) girls. METHOD Sexually abused girls and their caretakers (N = 159), of which 52% (n = 82) were AA (mean age 9.8 years, SD = 3.4, R = 6-17) and 48% (n = 77) were HN (mean age 10.1 years, SD = 3.8, R = 6-18), were included in the study. The mother/caretaker was administered a demographic form, the Achenbach's Child Behavior Checklist (CBCL), and the Family Assessment Measure (FAM-P). The child completed the FAM-C and the Trauma Symptom Checklist for Children (TSCC). The clinician completed the Parental Reaction to Incest Disclosure Scale (PRIDS). RESULTS HN girls were found to have a greater number of sexually abusive episodes and waited longer to disclose their abuse while AA girls were more likely to have experienced vaginal penetration. The perpetrators of HN girls were older and more likely to be fathers or stepfathers. The mothers/ caretakers of HN girls perceived their children as having significantly more aggressive behavior, anxiety/depression, somatic complaints, internalizing and externalizing behaviors, and had a higher total score on the CBCL than did AA girls. The HN girls were more likely to see their family as dysfunctional with confusion regarding family values and rules. HN mothers/caretakers perceived their families as more conflicted regarding adaptability and family controls. CONCLUSIONS HN girls experienced more emotional and behavioral problems, and both HN girls and their mothers/caretakers perceived their families as more disturbed and dysfunctional.
Collapse
Affiliation(s)
- J A Shaw
- Division of Child and Adolescent Psychiatry, University of Miami School of Medicine, FL 33101, USA
| | | | | | | | | |
Collapse
|
29
|
Abstract
We show that as a Type II supernova shock breaks out of its progenitor star, it becomes collisionless and may accelerate protons to energies >10 TeV. Inelastic nuclear collisions of these protons produce an approximately 1 h long flash of TeV neutrinos and 10 GeV photons, about 10 h after the thermal (10 MeV) neutrino burst from the cooling neutron star. A Galactic supernova in a red supergiant star would produce a photon and neutrino flux of approximately 10(-4) erg cm(-2) s(-1). A km(2) neutrino detector will detect approximately 100 muons, thus allowing to constrain both supernova models and neutrino properties.
Collapse
Affiliation(s)
- E Waxman
- Department of Condensed Matter Physics, Weizmann Institute, Rehovot 76100, Israel.
| | | |
Collapse
|
30
|
Macioch J, Liebson P, Daniels M, Johnson M, Ostoic T, Sandelski J, Loeb A, Kim S, Davidson M, Parrillo J, Feinstein S. SAI-10. Am J Cardiol 2001. [DOI: 10.1016/s0002-9149(01)01759-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
31
|
Lacour B, Laurent JF, Lenfant MH, Loeb A, Peuvrel P, Sauvage M, Toulouse C. [Clinical coding in oncology]. Bull Cancer 2001; 88:209-18. [PMID: 11257596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
32
|
Abstract
OBJECTIVE This study describes the emotional and behavioral responses of children who have been sexually victimized by juveniles (CC) 17 years of age and younger compared to child victims of adults (CA) 18 years of age and older. METHOD A total sample of N = 194 children and adolescents participated in the study, with 26% (n = 51) comprising CC and 74% (n = 143) encompassing CA. The mother/caretaker was administered a demographic form, Achenbach's Child Behavior Checklist (CBCL), and the Family Assessment Measure (FAM-P). The child was given the Family Assessment Measure (FAM-C) and the Trauma Symptom Checklist for Children (TSCC). The clinician completed the Parental Reaction to Incest Disclosure Scale (PRIDS). RESULTS No differences were found between the two groups for the type of sexual abuse, penetration, or the use of force. CC were younger and more likely to be males who were abused in a school setting, home, or a relative's home by a sibling or a non-related male. CC endorsed clinically significant sexual preoccupations and manifested borderline clinically significant symptomatology. CONCLUSIONS Children victimized by other children manifested elevated levels of emotional and behavioral problems and were not significantly different from those who had been sexually abused by adults.
Collapse
Affiliation(s)
- J A Shaw
- Division of Child and Adolescent Psychiatry, University of Miami School of Medicine, FL 33101, USA
| | | | | | | | | |
Collapse
|
33
|
Héry M, Teissier E, Ramaioli A, Loeb A, Mihura J, Veiten M, De Ghislain C, Weber B, Servent-Hanon V, Delozier T. L'âge inférieur ou égal à 40 ans est-il une contre-indication traitement conservateur ? Étude de 141 cas sans atteinte axiüaire (N−). Cancer Radiother 1998. [DOI: 10.1016/s1278-3218(98)80040-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
34
|
Abstract
The goals of this study were to determine the effects of recombinant human hemoglobin (rHb1.1, 1 g/kg i.v.) on systemic hemodynamics, regional blood flows, and regional vascular resistances in rats. Cardiac output (CO) and regional blood flow in 13 tissues were determined by using the radiolabeled-microsphere method during halothane anesthesia. Microspheres were injected at three time points: before (control, t = 0), t = 30 [10 min after a 20-min infusion of vehicle (diluent) or rHb1.1], and at t = 120 min. Infusion of diluent did not alter CO, heart rate (HR), mean arterial pressure (MAP), or systemic vascular resistance (SVR) and had minimal effects on regional blood flows. Infusion of rHb1.1 did not alter CO or HR but did increase MAP and SVR compared with diluent. Infusion of rHb1.1 increased blood flow to the heart and decreased blood flow to the gastrointestinal tract (GIT) and liver. Compared with the corresponding values in the diluent-treated rats, resistance was increased after rHb1.1 in spleen, kidney, and hepatic artery. In conclusion, rHb1.1 administration increased MAP and SVR. The vasoconstriction was heterogeneous and was associated with increased coronary blood flow and with increased regional resistance in kidney, spleen, and hepatic artery, compared with diluent-infused controls.
Collapse
Affiliation(s)
- A Loeb
- Department of Anesthesia, University of Pennsylvania Medical Center, Philadelphia 19104-4283, USA
| | | | | | | |
Collapse
|
35
|
Abstract
Maternal cocaine abuse has several deleterious effects in the newborn, including perinatal asphyxia, hypoxia, and hypercapnia. We hypothesized that chronic cocaine exposure during development may alter cerebral blood flow (CBF) regulation. We studied 16 neonatal rabbits that had received cocaine (20 mg/kg, i.p. b.i.d.) or saline since birth. Changes in CBF were measured by laser doppler flowmetry before (baseline), and during hypercapnia (FiCO2 = 7.5%), hypoxia (FiO2 = 12%), and asphyxia (apnea for 1 min). During hypercapnia, CBF increased less in cocaine than in control animals (28 +/- 3% vs. 69 +/- 10%, P < 0.05). During hypoxia, CBF increased similarly in both groups. During reventilation after asphyxia, CBF increased more in cocaine than in control animals (391 +/- 52% vs. 225 +/- 43%, P < 0.05). Chronic cocaine exposure during brain development appears to alter CBF regulation to hypercapnia and asphyxia, which may put the drug exposed newborn at risk for neurologic injury around birth.
Collapse
Affiliation(s)
- P Feuer
- Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, PA 19104, USA
| | | | | | | | | |
Collapse
|
36
|
Desai N, Kinzer D, Loeb A, Goldfarb J. Use of Synthetic Serum Substitute and alpha-minimum essential medium for the extended culture of human embryos to the blastocyst stage. Hum Reprod 1997; 12:328-35. [PMID: 9070721 DOI: 10.1093/humrep/12.2.328] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
This study was designed to provide further information on mouse and human embryo development in alpha-modified minimum essential medium (alphaMEM). First, we compared the development and implantation potential of murine in-vitro fertilized (IVF) embryos cultured in alphaMEM, in the presence and absence of co-culture cells. No significant difference was observed in blastocyst rate between alphaMEM alone (76.2%) and alphaMEM plus co-culture (79.9%). The percentage of hatched blastocysts was, however, higher with co-culture (47.5 versus 40%, P < 0.01). Transfer of blastocysts to pseudopregnant foster mothers resulted in similar live birth rates (14.9% alphaMEM alone versus 19.8% alphaMEM/co-culture). alphaMEM was also introduced into our clinical IVF programme for culture of human embryos beyond day 3. Spare human embryos were cultured under oil in microdrops of alphaMEM supplemented with 10% synthetic serum substitute. Blastocysts were evaluated for maturity and the presence and organization of the inner cell mass. A total of 206 embryos from 53 IVF patients underwent extended culture. The overall blastocyst rate was 45.1%. An inner cell mass was observed in 76 blastocysts (81.7%). With regard to developmental maturity, approximately 73% of blastocysts that had been frozen were expanding (cavity > 50% embryo volume) or fully expanded. These data suggest that alphaMEM in conjunction with a commercial protein preparation such as Synthetic Serum Substitute may be a good basal medium for culture of human embryos to the blastocyst stage.
Collapse
Affiliation(s)
- N Desai
- Department of Reproductive Biology, Case Western Reserve University, Cleveland, OH 44106, USA
| | | | | | | |
Collapse
|
37
|
|
38
|
Loeb A. Are gamma -ray bursts at cosmological distances optically thin? Phys Rev D Part Fields 1993; 48:R3419-R3421. [PMID: 10016673 DOI: 10.1103/physrevd.48.r3419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
39
|
|
40
|
Korevaar W, Zavitsanos T, Loeb A. A815 THERMOGRAPHIC SYMMETRY AND RESOLUTION OF PAIN IN REFLEX SYPATHETIC DYSTROPHY. Anesthesiology 1990. [DOI: 10.1097/00000542-199009001-00813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
41
|
|
42
|
Loeb A, Stodolsky L. Relativistic spin relaxation in stochastic electromagnetic fields. Phys Rev D Part Fields 1989; 40:3520-3524. [PMID: 10011722 DOI: 10.1103/physrevd.40.3520] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
43
|
Loeb A. Collisional incoherence in neutrino line emission. Phys Rev D Part Fields 1989; 39:1009-1012. [PMID: 9959736 DOI: 10.1103/physrevd.39.1009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
44
|
|
45
|
Abstract
A simplified analytic model of a cooling hot neutron star, motivated by detailed computer calculations, describes well the neutrinos detected from the recent supernova in the Large Magellanic Cloud. The observations do not require explanations that invoke exotic physics or complicated astrophysics. The parameters in this simple model are not severely constrained: 6.1(-3.6)(+3.5) x 10(52) ergs emitted in electron antineutrinos, a peak temperature of 4.2(-0.8)(+1.2) megaelectron volts, a radius of 27(-15)(+17) kilometers, and a cooling time of 4.5(-2.0)(+1.7) seconds.
Collapse
|
46
|
Loeb A, Friedland L, Eliezer S. Autoresonance laser acceleration of guided "quasineutral" electron-positron beams. Phys Rev A Gen Phys 1987; 35:1692-1696. [PMID: 9898331 DOI: 10.1103/physreva.35.1692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
47
|
Loeb A, Eliezer S. Free-electron laser and laser electron acceleration based on the megagauss magnetic fields in laser-produced plasmas. Phys Rev Lett 1986; 56:2252-2255. [PMID: 10032933 DOI: 10.1103/physrevlett.56.2252] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
48
|
|
49
|
Owens GK, Loeb A, Gordon D, Thompson MM. Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol 1986; 102:343-52. [PMID: 3944187 PMCID: PMC2114077 DOI: 10.1083/jcb.102.2.343] [Citation(s) in RCA: 373] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
The relationship between growth and cytodifferentiation was studied in cultured rat aortic smooth muscle cells (SMCs) using expression of the smooth muscle (SM)-specific isoactins (Vanderkerckhove, J., and K. Weber, 1979, Differentiation, 14:123-133) as a marker for differentiation in these cells. Isoactin expression was evaluated by: (a) measurements of fractional isoactin content and synthesis ([35S]methionine incorporation) by densitometric evaluation of two-dimensional isoelectric focusing sodium dodecyl sulfate gels, and (b) immunocytological examination using SM-specific isoactin antibodies. Results showed the following: (a) Loss of alpha-SM isoactin was not a prerequisite for initiation of cellular proliferation in primary cultures of rat aortic SMCs. (b) alpha-SM isoactin synthesis and content were low in subconfluent log phase growth cells but increased nearly threefold in density-arrested postconfluent cells. Conversely, beta-nonmuscle actin synthesis and content were higher in rapidly dividing subconfluent cultures than in quiescent postconfluent cultures. These changes were observed in primary and subpassaged cultures. (c) alpha-SM actin synthesis was increased by growth arrest of sparse cultures in serum-free medium (SFM; Libby, P., and K. V. O'Brien, 1983, J. Cell. Physiol., 115:217-223) but reached levels equivalent to density-arrested cells only after extended periods in SFM (i.e., greater than 5 d). (d) SFM did not further augment alpha-SM actin synthesis in postconfluent SMC cultures. (e) Serum stimulation of cells that had been growth-arrested in SFM resulted in a dramatic decrease in alpha-SM actin synthesis that preceded the onset of cellular proliferation. These findings demonstrate that cultured vascular SMCs undergo differential expression of isoactins in relation to their growth state and indicate that growth arrest promotes cytodifferentiation in these cells.
Collapse
|
50
|
Abstract
Nutritional shifts of Escherichia coli B/r to richer media have been analyzed is synchronously growing and exponential-hase populations. Early perturbations in the timing of cell division were observed. At the slow growth, division progressed at a rate equal to or less than the preshift rate for about 1 h. At intermediate growth, both delays and acceleration in division were observed. The extent of the perturbation depended upon the age of the cells at the time of the shift and the composition of the preshift and postshift media. The perturbation was different in the two substrains of E. coli B/r used in this study.
Collapse
|